In the first half of 2025, global healthcare buyout deal value fell slightly below 2024 on an annualized basis. The second quarter in particular saw a drop in value, which was most pronounced in medical technology and biopharma. Still, deal value was higher compared with the first half of 2024. Regionally, North America was weaker than during the same period a year earlier. In Asia-Pacific, deal volume in India was buoyed by major provider deals, and Japan hosted large carve-outs. Growth slowed in many other Asia-Pacific countries. By contrast, dealmaking in Europe has more or less held steady throughout the past six quarters.
Read the full article: Bain: Deal Markets Recalibrate – Healthcare Private Equity 2025 Midyear Update //
Source: https://www.bain.com/insights/deal-markets-recalibrate-healthcare-private-equity-midyear-update-snap-chart/